Thoracic metastasis in advanced ovarian cancer: Comparison between computed tomography and video-assisted thoracic surgery

Journal of Gynecologic Oncology

Volumn 22, Issue 4, 2011, Pages 260-268

  Mironov, Oleg ^a   Sala, Evis ^b   Mironov, Svetlana ^a   Pannu, Harpreet ^a   Chi, Dennis S ^a   Hricak, Hedvig ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Computed tomography; Malignant diagnosis; Ovarian neoplasms; Pleural effusion; Pleural neoplasms; Thoracic surgery video assisted

Indexed keywords

ADULT; AGED; ASCITES; ASCITES FLUID CYTOLOGY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG METASTASIS; LUNG NODULE; LYMPHADENOPATHY; OVARY CARCINOMA; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA FLUID; RETROSPECTIVE STUDY; REVIEW; TUMOR SEEDING; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84857660790     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2011.22.4.260     Document Type: Review

References (35)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25.
2. FIGO Committee on Gynecologic Oncology, Denny L, Hacker NF, Gori J, Johns HW III, Ngan HY, et al. Staging classifications and clinical practice guidelines for gynecologic cancers. Oxford: Elsevier; 2000.
3. Ozols RF. Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer. Cancer Invest 2004;22 Suppl 2:11-20.
4. Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006;106:1933-9.
5. Morgan RJ Jr, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen LM, et al. NCCN Clinical Practice Guidelines in Oncology: epithelial ovarian cancer. J Natl Compr Canc Netw 2011;9:82-113.
6. Kim KW, Choi HJ, Kang S, Park SY, Jung DC, Cho JY, et al. The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer. Eur J Radiol 2010;75:230-5.
7. Diaz JP, Abu-Rustum NR, Sonoda Y, Downey RJ, Park BJ, Flores RM, et al. Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. Gynecol Oncol 2010;116:483-8.
8. Munstedt K, Franke FE. Role of primary surgery in advanced ovarian cancer. World J Surg Oncol 2004;2:32.
9. Huober J, Meyer A, Wagner U, Wallwiener D. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. J Cancer Res Clin Oncol 2002; 128:153-60.
10. Schwartz PE. Cytoreductive surgery for the management of stage IV ovarian cancer. Gynecol Oncol 1997;64:1-3.
11. Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Eoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010;363:943-53.
12. Eitan R, Levine DA, Abu-Rustum N, Sonoda Y, Huh JN, Franklin CC, et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer 2005;103:1397-401.
13. Juretzka MM, Abu-Rustum NR, Sonoda Y, Downey RJ, Flores RM, Park BJ, et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecol Oncol 2007; 104:670-4.
14. Chi DS, Abu-Rustum NR, Sonoda Y, Chen SW, Flores RM, Downey R, et al. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol 2004;94:307-11.
15. Mironov O, Ishill NM, Mironov S, Vargas HA, Zheng J, Moskowitz CS, et al. Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. Radiology 2011;258:776-84.
16. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990;154: 487-92.
17. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 2001;56:193-6.
18. Grunze H. The comparative diagnostic accuracy, efficiency and specificity of cytologic technics used in the diagnosis of malignant neoplasm in serous effusions of the pleural and pericardial cavities. Acta Cytol 1964;8:150-63.
19. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907-13.
20. Sallach SM, Sallach JA, Vasquez E, Schultz L, Kvale P. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest 2002;122:1913-7.
21. Lim MC, Lee HS, Jung DC, Choi JY, Seo SS, Park SY. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol 2009;16: 1990-6.
22. Mergo PJ, Helmberger T, Didovic J, Cernigliaro J, Ros PR, Staab EV. New formula for quantification of pleural effusions from computed tomography. J Thorac Imaging 1999;14:122-5.
23. du Bois A, Quinn M, Thigpen T, Vermorken J, Avall-Lundqvist E, Bookman M, et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005;16 Suppl 8:viii7-12.
24. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer: Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995;332:629-34.
25. Bonnefoi H, A'Hern RP, Fisher C, Macfarlane V, Barton D, Blake P, et al. Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 1999;17:767-75.
26. Penson RT, Skates SJ, Fuller AJ Jr, Seiden MV. Clinical course of stage IV epithelial ovarian cancer. J Clin Oncol 1999;17: 3361-2.
27. Aletti GD, Podratz KC, Cliby WA, Gostout BS. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment. Gynecol Oncol 2009;112:22-7.
28. Eisenkop SM. Thoracoscopy for the management of advanced epithelial ovarian cancer: a preliminary report. Gynecol Oncol 2002;84:315-20.
29. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
30. Munkarah AR, Hallum AV 3rd, Morris M, Burke TW, Levenback C, Atkinson EN, et al. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol 1997;64:13-7.
31. Cohen-Mouly S, Badia A, Bats AS, Barthes F, Bensaid C, Riquet M, et al. Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion. Int J Gynecol Cancer 2009;19:1662-5.
32. Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 2000; 175:245-9.
33. Orki A, Akin O, Tasci AE, Ciftci H, Urek S, Falay O, et al. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases. Thorac Cardiovasc Surg 2009;57:217-21.
34. Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, et al. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. J Thorac Oncol 2009;4:1480-4.
35. Kitajima K, Murakami K, Yamasaki E, Kaji Y, Fukasawa I, Inaba N, et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging 2008;35:1912-20.